mynth
10/2026

MEDISSIMO acquired by CORAVIA

FRANCE Life Sciences / Medical Devices / Medical Consumables REV €5–25M

Context

Coravia acquired Medissimo, the Poissy-based maker of secure pill organisers, in a transaction announced on 15 October 2026, alongside a 19 million euro minority investment by NextStage AM in its own capital. Medissimo generated revenue of €5–25M, taking the combined group to 35 million euros and around 250 employees. The purchase made Coravia the leading French supplier of semi-automatic equipment for preparing medication doses, the machines and software with which pharmacists fill the organisers used by elderly patients. Coravia had entered that market in 2021 by acquiring Oreus, which serves the pharmacists that care homes subcontract to fill their residents’ organisers. Medissimo covers the other half of the market, the pharmacists preparing organisers for patients living at home, which founder Alexandre Bataille presented as giving the group the whole of it. The acquisition fitted a sequence built since 2016, when Bataille bought the slipper manufacturer Fargeot & Cie and turned its therapeutic footwear brand Podowell into the core of the business. Oreus followed in 2021, then CRMS in 2024, which installs call systems in care homes and hospitals, and shortly afterwards Telegrafik, the Toulouse start-up developing sensors to support independent living at home. All of them share the same customers: Coravia counts 7,000 pharmacists among them.

-> Deep-dive in Healthcare & Pharma market trends

Target

Medissimo designs and supplies secure pill organisers and the equipment used to fill them. Its products hold a patient’s medication arranged by day and by time, sealed so that each dose can only be removed when it is due, and it sells the semi-automatic machines and software that pharmacists use to prepare them. Its customers are pharmacists who fill organisers for patients living at home, and the company is based in Poissy, in the Yvelines.

Ent. Value

€5–25M

Equity Value

[members only]

Multiples

EV / Revenue

[members only]

EV / EBITDA

[members only]

EV / EBIT

[members only]

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2026
€5–25M
[members only]
[members only]
2025
€5–25M
[members only]
[members only]

Similar deals in Life Sciences

Similar deals in Life Sciences

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
DateAcquirerTargetCountrySector
10/2026APHEONHAGER & MEISINGERGERMANYMedical Consumables
10/2026NEXTSTAGECORAVIAFRANCEMedical Consumables
09/2026Telix PharmaceuticalsITM ISOTOPE TECHNOLOGIESGERMANYPharma & Biotech
09/2026Yellow Wood PartnersNestlé VMS businessSWITZERLANDNutrition & Dietary Supplements
08/2026TELEDYNE TECHNOLOGIES INCORPORATEDVarex ImagingUNITED STATESDiagnostic Equipment
08/2026ZIMMER BIOMETMonogram TechnologiesUNITED STATESMedical Devices
08/2026STADAORIFARM VMSDENMARKNutrition & Dietary Supplements
08/2026WISE EQUITYE-Pharma TrentoITALYCDMO
07/2026YOTTA CAPITAL / OUEST CROISSANCELes Laboratoires HerbolistiqueFRANCENutrition & Dietary Supplements
07/2026BC PARTNERSInfoRLifeSWITZERLANDCDMO

REFERENCES

Revenue range: €5–25M

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of MEDISSIMO by CORAVIA are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Target: medissimo

Acquirer: coravia